5 Pharmaceutical products and preparations for the treatment of cardiovascular and respiratory diseases, pulmonary fibrosis, sarcoidosis, lung disease, viral diseases, and infectious diseases; chemical preparations for sanitary purposes for medicine; pharmaceutical products for the treatment of idiopathic pulmonary arterial hypertension, familial pulmonary arterial hypertension, scleroderma, lupus erythematosus associated pulmonary hypertension, congenital systemic-to-pulmonary shunts associated pulmonary hypertension, portal hypertension associated pulmonary hypertension, HIV infection associated pulmonary hypertension, drugs and toxins associated pulmonary hypertension, glycogen storage disease associated pulmonary hypertension, Gaucher disease associated pulmonary hypertension, hereditary hemorrhagic telangiectasia associated pulmonary hypertension, hemoglobinopathies associated pulmonary hypertension, myeloproliferative disorders associated pulmonary hypertension, pulmonary veno-occlusive disease associated pulmonary hypertension, pulmonary capillary hemangiomatosis associated pulmonary hypertension, persistent pulmonary hypertension of the newborn, left-sided atrial or ventricular heart disease associated pulmonary hypertension, left-sided valvular heart disease associated pulmonary hypertension, pulmonary hypertension associated with chronic obstructive pulmonary disease, pulmonary hypertension associated with interstitial lung diseases, pulmonary hypertension associated with sleep disordered-breathing, pulmonary hypertension associated with alveolar hypoventilation disorders, pulmonary hypertension associated with chronic exposure to high altitude, pulmonary hypertension associated with developmental abnormalities, pulmonary hypertension due to chronic thrombotic and embolic diseases, pulmonary embolism due to tumor, parasites, foreign material, pulmonary hypertension associated with in situ thrombosis, pulmonary hypertension associated with sarcoidosis, pulmonary hypertension associated with histiocytosis X, pulmonary hypertension associated with lymphangiomatosis, pulmonary hypertension associated with sickle-cell disease, Eisenmenger syndrome, chronic fatigue syndrome, bronchial asthma, rheumatoid arthritis, lupus, Goodpasture's syndrome, Wegener's granulomatosis, type 1 diabetes mellitus, Hashimoto's thyroiditis, Grave's disease, multiple sclerosis, Guillain-Barre syndrome, Addison's disease, acute disseminated encephalomyelitis, antiphospholipid antibody syndrome, aplastic anemia, myasthenia gravis, opsoclonus myoclonus syndrome, optic neuritis, Ord's thyroiditis, acute respiratory distress syndrome, acute lung injury, Hamman-Rich syndrome, idiopathic pulmonary fibrosis, bronchiolitis obliterans, hypersensitivity pneumonitis, lymphangiomyomatosis (LAM), usual interstitial pneumonia (UIP), Von Gierke syndrome, Osler-Weber-Rendu-Syndrome, small cell lung carcinoma, cystic fibrosis, tuberculosis, Hepatitis B virus infections, psoriasis, allergic dermatitis, scar keloids, pyogenic granulomas, blistering disease, Kaposi sarcoma in AIDS patients, systemic sclerosis, persistent hyperplastic vitreous syndrome, diabetic retinopathy, retinopathy of prematurity, choroidal neovascularization, inflammatory bowel disease, periodontal disease, ascites, peritoneal adhesions, endometriosis, uterine bleeding, ovarian cysts, ovarian hyperstimulation, osteomyelitis, osteophyte formation, HIV-induced bone marrow angiogenesis, early diabetic nephropathy, cancer and malignancies and their metastases in numerous organs, hemangiomas, vasculitis, Sjögren's disease, DiGeorge syndrome, hereditary haemorrhagic telangiectasia, cavernous hemangioma, cutaneous hemangioma, lymphatic malformations, transplant arteriopathy, vascular anastomoses, adipose tissue in obesity, chronic allograft rejections; chemical preparations intended for healing, health care or medical and veterinary purposes, namely, chemical preparations for treating inflammatory, cardiovascular and respiratory diseases, pulmonary fibrosis, sarcoidosis, lung disease, viral diseases, and infectious diseases; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes; radiological contrast substances for medical purposes; detergents for medical purposes; medicated mouth care and treatment preparations; medicated skin care preparations
Trademark: 79142915
